Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
How to prepare for the Fed's forthcoming interest rate cuts
Recommended
What to know about Labor Day and its history
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biogen Idec
(NQ:
BIIB
)
203.30
-1.56 (-0.76%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Biogen Idec
< Previous
1
2
...
33
34
35
36
37
38
39
40
Next >
What 18 Analyst Ratings Have To Say About Biogen
July 16, 2021
Within the last quarter, Biogen (NASDAQ:BIIB) has observe...
Via
Benzinga
Stock Market Rally Struggles Outside Apple; JPMorgan, Goldman, UnitedHealth, Taiwan Semi Are Key Earnings
July 16, 2021
Apple hit record highs, but the stock market quietly struggled this week. JPMorgan, Goldman, Taiwan Semi kicked off earnings.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
FibroGen Stock Collapses After FDA Panel Rejects Anemia Treatment
July 16, 2021
A FDA panel voted resoundingly against recommending approval for an anemia treatment from FibroGen, and FGEN stock tanked on Friday.
Via
Investor's Business Daily
Exposures
Product Safety
Better Biotech Stock: Biogen vs. Annovis Bio
July 16, 2021
Both are making Alzheimer's drugs, but only one can claim success as of today.
Via
The Motley Fool
Friday Trades And June Summary
July 03, 2021
Trading performance has been very good year to date. I had thought I needed to tighten my belt but I made it by just fine.
Via
Talk Markets
AMD And Biogen Lead The QQQ Lower Thursday
July 15, 2021
U.S. indices were trading lower Thursday as investors weigh Fed Chair Powell’s comments on inflation to the Senate banking panel. ...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
BIIB Stock: The Drug Ban News That Has Biogen Stumbling Today
July 15, 2021
BIIB stock is losing out today, as two major hospitals have declined to use Biogen's controversial new Alzheimer's drug on their campuses.
Via
InvestorPlace
Biogen Shares Are Trading Lower As Cleveland Clinic, Mount Sinai Decline To Aduhelm Administration
July 15, 2021
A pair of large hospitals have declined to administer Biogen Inc’s (NASDAQ: BIIB) Alzheimer’s treatment Aduhelm, Wall Street Journal reported. The...
Via
Benzinga
Biogen Stock Dives After Cleveland Clinic, Mount Sinai Ban Alzheimer's Drug Aduhelm
July 15, 2021
Biogen stock tumbled Thursday after the Cleveland Clinic and Mount Sinai said they won't administer the company's Alzheimer's drug, Aduhelm.
Via
Investor's Business Daily
Biogen's Alzheimer's Drug Aduhelm Review Could Have Been Handled Differently, Says FDA Chief: STAT News
July 15, 2021
Acting FDA Commissioner Janet Woodcock pushed back against media questions about the agency's controversial approval of Alzheimer's treatment, Aduhelm developed by ...
Via
Benzinga
Exposures
Product Safety
Biogen Stock And The Aduhelm Drama: Will It Really Treat Alzheimer's?
July 15, 2021
The fate of Biogen stock is now intricately tied to the success — or failure — of its controversial Alzheimer's treatment, Aduhelm.
Via
Investor's Business Daily
US Medicare Starts Coverage Policy Review For Biogen's Aduhelm
July 13, 2021
The U.S. government started a review process for national Medicare coverage of Biogen Inc's (NASDAQ: BIIB) Alzheimer's drug, Aduhelm. The Centers for...
Via
Benzinga
The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data
July 13, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 12) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
COVID-19
Biogen, InnoCare Collaborate On Multiple Sclerosis Candidate
July 13, 2021
Biogen Inc (NASDAQ: BIIB) is paying $125 million upfront to work on InnoCare Pharma Limited's orelabrutinib, a small oral molecule Bruton's...
Via
Benzinga
Tesla And Lam Research Lead The QQQ Higher Monday
July 12, 2021
Major U.S. indices managed to all finish with record closing highs Monday as investors continue to weigh last week’s sell-off over conce...
Via
Benzinga
The Week Ahead In Biotech: Adcom Test Awaits FibroGen, Data Readouts, IPOs In The Mix
July 11, 2021
Biopharma stocks closed the holiday-shortened week lower amid a lack of any significant news flow. On the drug approval front, Provention Bio, Inc. (NASDAQ: PRVB) faced a setback...
Via
Benzinga
Biogen Stock Drags On Alzheimer's Players As FDA Requests Review Of Aduhelm Approval
July 09, 2021
Biogen stock tumbled Friday after the FDA requested an independent review of the process that led to its recent Alzheimer's approval.
Via
Investor's Business Daily
Exposures
Product Safety
Biogen Slides As FDA Calls For Investigation Into Approval Of Controversial Alzheimer's Drug
July 09, 2021
Shares of Biogen sank to their lowest levels of the session, weighing on the broader biotech sector.
Via
Talk Markets
Exposures
Product Safety
FDA Requests Probe Into Staff Interactions With Biogen Ahead Of Aduhelm Approval
July 09, 2021
Biogen Inc. (NASDAQ:BIIB) shares came under pressure Frida...
Via
Benzinga
Exposures
Product Safety
Understanding Biogen's Unusual Options Activity
July 09, 2021
On Friday, shares of Biogen (NASDAQ:BIIB) saw unusual options activity. After the option alert, the stock price moved up to $369.73. Sentiment: BULLISH Option Type: SWEEP Trade...
Via
Benzinga
Cramer Shares His Thoughts On Anavex Life Sciences, Upstart And More
July 09, 2021
On CNBC's "Mad Money Lightning Round," Jim Cramer said he is intrigued about Anavex Life Sciences Corp (NASDAQ: AVXL) because Biogen Inc (NASDAQ: BIIB) data doesn...
Via
Benzinga
Should Biogen Worry About a Congressional Investigation Into Its Alzheimer's Disease Drug?
July 09, 2021
The company faces hard questions from a House committee about the pricing of Alzheimer's disease drug Aduhelm.
Via
The Motley Fool
Exposures
Product Safety
What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.
July 08, 2021
What did the stock market do today? Well, it did a little bit of everything, with short squeezes, crypto gains, IPO hype and regulation fears.
Via
InvestorPlace
Topics
Initial Public Offering
Exposures
Securities Market
Baidu And Nvidia Lead The QQQ Lower Thursday
July 08, 2021
U.S. indices were trading lower Thursday amid concerns the economic recovery is slowing. Growing concerns over the COVID-19 Delta variant have also...
Via
Benzinga
Exposures
COVID-19
Forget a Bear Market -- These 2 Nasdaq Stocks Are Moving Higher
July 08, 2021
Even with markets suffering, there were still some positives on Wall Street.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Biogen Stock Pops Despite New FDA Limits On Alzheimer's Drug Use
July 08, 2021
Biogen stock rose Thursday after the Food and Drug Administration signed off on narrower recommendations for Alzheimer's drug Aduhelm.
Via
Investor's Business Daily
Exposures
Product Safety
FDA Narrows Label To Recommend Use Of Biogen's Aduhelm In Mild Alzheimer's Patients
July 08, 2021
Biogen Inc. (NASDAQ:BIIB) shares are lower after the compa...
Via
Benzinga
Exposures
Product Safety
Oracle And CarMax Lead The SPY Higher Wednesday
July 07, 2021
U.S. indices were trading higher Wednesday after the 10-year treasury yield fell to its lowest level since February at 1.3%. The ...
Via
Benzinga
Is Eli Lilly a Better Alzheimer's Stock Than Biogen?
July 07, 2021
An unusually lenient FDA is a knife that cuts both ways for Biogen.
Via
The Motley Fool
Exposures
Product Safety
Unusual Options Activity Insight: Biogen
July 06, 2021
Biogen (NASDAQ:BIIB) shares experienced unusual options activity on Tuesday. The stock price moved down to $343.7 following the option alert. Sentiment: NEUTRAL Option Type:...
Via
Benzinga
< Previous
1
2
...
33
34
35
36
37
38
39
40
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.